정신분열병 환자의 혈청에서 Brain-Derived Neurotrophic Factor 증가 = Serum Brain-Derived Neurotrophic Factor in Schizophrenia

다국어 초록 (Multilingual Abstract)

Objectives:Abnormalities in neurotrophic factors that regulate neuronal development and synaptic plasticity are often implicated as some causes of schizophrenia. In previous studies, researchers reported that brain and serum BDNF levels underwent similar changes during maturation and aging processes in rats. They also found a positive correlation between serum and cortical BDNF levels. In this study, we investigated whether the serum levels of BDNF in Korean schizophrenic patients would be different from those of healthy controls. Methods:Using an ELISA kit, serum BDNF levels were assessed in schizophrenic group(N=49) and control group(N=50). Results:Serum BDNF levels in the schizophrenic group($36.29{\pm}19.78$ng/ml) were significantly higher than those in control group($22.4{\pm}14.4$ng/ml). The BDNF levels did not correlate with duration of treatment, age or daily dose of antipsychotics in patients with schizophrenia. Conclusions:This result suggests that schizophrenia is characterized by high serum BDNF levels and supports the hypothesis of neurotrophic factor involvement in psychotic disorder. Serum BDNF level is likely to be one of the possible biological markers for schizophrenia.

참고문헌 (Reference)

1 "from molecule to man Trends in Neuroscience1994;17" 182-189

2 "Transport of brain-derived neurotrophic factor acrossthe blood-brain barrier" 37 : 1553-1561, 1998

3 "The association betweenseason of birth and the risk for schizophrenia AmericanJournal of Epidemiology 1981;114" 735-749,

4 "Schizophrenia after prenatal famine" 53 : 25-31, 1996

5 "Schizophrenia after prenatal exposure to 1957 A2 influenzaepidemic" 1248-1250, lancet1991;25

6 "Regulation of BDNFand trkB m RNA in rat brain by chronic electroconvulsiveseizure and antidepressant drug treatment" 15 : 7539-7547, 1995

7 "Presence of BDNF in brain andhuman and rat but not mouse serum detected by a sensitiveand specific immunoassay" 709 : 122-301, 1996

8 "Postnatal developmentalprofile of brain-derived neurotrophic factor in rat brainand platelets" 328 : 261-264, 2002

9 "Perinatal risk factors and schizophrenia:selective review and methodological concerns" 17 : 107-112, 1995

10 "Performance of heterozygousbrain-derived neurotrophic factor knockout mice on behavioranalogues of anxiety nociception, and depression" 115 (115): 1145-1153, 2001

11 "Neuropeptides and neurotrophinsin neonatal blood of children with autism or mentalretardation" 49 : 597-606, 2001

12 "Nerve growthfactor levels in normal human sera" 8 : 179-181, 1996

13 "Low nerve growth factor plasma levels inschizophrenic patients." 37 : 197-203, 1999

14 "Increased hippocampal BDNF immunoreactivityin subjects treated with antidepressant medication" 50 : 260-265, 2001

15 "Human platelet containbrain-derived neurotrophic factor" 10 : 3469-3478, 1990

16 "Effects of family history andplace and season of birth on the risk of schizophrenia" 340 : 603-608, 1999

17 "Decreased levelsof brain-derived neurotrophic factor in serum of chronicschizophrenic patients" 110 : 249-257, 2002

18 "Critical review of recent adoptiontwin and family study of schizophrenia:Behaviorgenetics perspectives." 360-401, 1976;2

19 "Cellular location of the Trkneurotrophin receptor family in human non-neuronal tissues" 148 : 1807-1818, 1996

20 "Brain-derived neurotrophicfactor and neurotrophin-3 in schizophrenic psychoses" 9 : 79-86, 2000

21 "BDNF is reduced in Alzheimer’s disease" 49 : 71-81, 1997

22 "BDNF and neurotrophin-3 levels in Alzheimer’s disease brains" 18 : 807-813, 2003

23 "Abnormal expression ofBDNF and its receptor in the corticolimbic system ofschizophrenic patients" 5 : 293-300, 2000